Long-term Clinical Safety of FEIBA, Activated Prothrombin Complex Concentrate (aPCC) in Japanese Inhibitor Subjects: An Update of Post-Authorization Safety Surveillance (PASS) Program
Long-term Clinical Safety of FEIBA, Activated Prothrombin Complex Concentrate (aPCC) in Japanese Inhibitor Subjects: An Update of Post-Authorization Safety Surveillance (PASS) Program
复制标题
FEIBA、活化凝血酶原复合物浓缩物 (aPCC) 在日本抑制剂受试者中的长期临床安全性：授权后安全监测 (PASS) 计划的更新
DOI：
--
复制
发表时间：
2012
期刊：
影响因子：
--
通讯作者：
Michio Sakai and the FINE study group
中科院分区：
文献类型：
--
作者：
Midori Shima;Kagehiro Amano;Ei Kinai;Shinji Muto;Tadashi Matsushita;Satoshi Higasa;Teruhisa Fujii ;Michio Sakai and the FINE study group
